When Katherine Stueland was 11 years old, she went to a reunion for her mother’s branch of the family tree and learned that ...

A therapy using a patient's own proximal basal stem cells shows promise to treat idiopathic pulmonary fibrosis.

Programs address the need for disease-modifying therapies targeting root causes of fibrosis Funding will support advancement of CCN-family inhibitor TRX-44 into clinical trials for treatment ...

Novo Holdings today announced its participation in a ?23 million Series A round for Tribune Therapeutics ('Tribune'). The round was led by new investor LifeArc Ventures and joined by Novo Holdings, ...

Tribune raises EUR 37 million in seed and Series A funding to advance portfolio of therapies targeting central drivers of ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...

Company to present key research advancing digital pathology and host a networking event, H&E by the Sea, on March 25th at ...